ARTL Overview

Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, helping them stay informed and make timely decisions in the stock market.

Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters, enhancing the trading experience for its users.

Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, fostering a collaborative environment for sharing market intelligence.

Market Success: Traders utilize Benzinga Pro's resources to gain a competitive edge and improve their chances of winning in the markets daily.

Wolfspeed's Reorganization: Wolfspeed, Inc. announced a court-approved reorganization plan that will reduce its debt by 70% and interest payments by 60%, leading to a 50.9% increase in its stock price during pre-market trading.

Other Notable Stock Movements: Several companies saw significant pre-market trading gains, including Sunrise New Energy Co. (up 97%) and Vivakor, Inc. (up 67%), while others like Epsium Enterprise Limited and Artelo Biosciences, Inc. experienced notable declines.

Public Offering Announcement: Artelo Biosciences has initiated an underwritten public offering of its common stock and/or pre-funded warrants, with all shares being offered by the company.

Market Conditions Impact: The completion, final size, and terms of the offering are contingent on market conditions, and there is no assurance regarding the timing or completion of the offering.

Public Offering Announcement: Artelo Biosciences, Inc. has initiated an underwritten public offering of its common stock and/or pre-funded warrants, with the offering subject to market conditions and no assurance of completion or specific terms.

Company Overview: Artelo Biosciences is a clinical-stage pharmaceutical company focused on developing treatments for various conditions, including cancer and pain, by modulating lipid-signaling pathways, and is led by an experienced executive team.

Analyst Downgrades: JP Morgan downgraded Science Applications International Corporation (SAIC) from Overweight to Neutral, lowering the price target from $140 to $115, with shares closing at $104.93.

Artelo Biosciences Rating Change: D. Boral Capital downgraded Artelo Biosciences, Inc. from Buy to Hold, with shares closing at $4.51.

ABM Industries Adjustment: Baird analyst downgraded ABM Industries Incorporated from Outperform to Neutral, reducing the price target from $56 to $54, while shares closed at $48.26.

Market Overview: The article provides insights into various stock performances and analyst ratings, highlighting significant changes in outlook for several companies.

Public Offering Details: Artelo Biosciences, Inc. closed an underwritten public offering of 640,924 shares of common stock at $4.40 per share, along with pre-funded warrants for 40,894 shares at $4.399 each, raising approximately $3 million in gross proceeds.

Market Performance: Following the offering, Artelo's stock closed at $4.51, reflecting a 3.68% increase, with no after-hours trading activity reported on NasdaqCM.